Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

76.23 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
37 38 Next >
Investing $1,000 in These 2 Top Growth Stocks Would Be a Brilliant Move
This move might not pay off immediately, but it eventually will. 
Via The Motley Fool
Elliott Wave Technical Analysis: DexCom Inc. - Tuesday, May 23
Looking for further upside with a stop below wave E. 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
 
Via Benzinga
What Recession? These Companies Expect 20% Sales Growth This Year.
Recession or not, don't expect these businesses to run out of growth opportunities anytime soon. 
Via The Motley Fool
S&P 500 Medtech Play DexCom Leads Five Stocks Near Buy Points
These stocks offer investors a variety of options across multiple sectors. 
Via Investor's Business Daily
How Is The Market Feeling About DexCom?
 
Via Benzinga
Check Out What Whales Are Doing With DXCM
 
Via Benzinga
DexCom Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Elliott Wave Technical Analysis: DexCom Inc, Monday, May 1
DexCom Inc.broke through confirmation by breaking the green line and we are pulling back as expected. Looking for further upside into wave 3. 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
3 HealthTech Stocks to Watch as Digital Health Transforms the Industry
Healthtech is a large and growing field. These are three of the best healthtech stocks to buy for innovation-oriented investors right now. 
Via InvestorPlace
Dexcom Prices Upsized Offering of $1.1 Billion of 0.375% Convertible Senior Notes Due 2028
From DexCom, Inc.
Via Business Wire
Dexcom Announces Proposed Offering of $1.0 Billion of Convertible Senior Notes
From DexCom, Inc.
Via Business Wire
DexCom (DXCM) Q1 2023 Earnings Call Transcript
DXCM earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Check Out What Whales Are Doing With DXCM
 
Via Benzinga
Is Dexcom a Good Stock to Buy Now?
A poorly received first-quarter earnings report has investors wondering if this stock's best days are behind it. 
Via The Motley Fool
1 Stock-Split Stock That's a Surefire May Buy and 1 to Avoid
A half-dozen, high-profile companies split their stock last year. One stands out as an exceptional value in May, while another is seeing its competitive advantages erode. 
Via The Motley Fool
Amazon Leads 5 S&P 500 Stocks Near Buy Points After Earnings
Given recent earnings blowups, stocks that have already reported are worth watching. 
Via Investor's Business Daily
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
Microsoft, Meta, Cloudflare and Crocs were among the many big movers. 
Via Investor's Business Daily
Top 2% Stock Dexcom Easily Beats First-Quarter Expectations, Boosts Outlook
Dexcom is benefitting from the shift to continuous glucose monitors in diabetes management. 
Via Investor's Business Daily
2 Growth Stocks That Could Double in 5 Years
Both of these companies did more than that in the past five years. 
Via The Motley Fool
Roblox And 3 Other Stocks Insiders Are Selling
The Nasdaq Composite closed sharply higher on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Mastercard To Rally Over 18%? Here Are 10 Other Analyst Forecasts For Friday
Wells Fargo raised the price target for Molina Healthcare, Inc. (NYSE: MOH) from $282 to $290. Wells Fargo analyst Stephen Baxter maintained an Underweight rating. Molina Healthcare shares gained 7.8%... 
Via Benzinga
DexCom Q1 Earnings Beat Sets Stage For Upcoming Catalysts During 2023, Analyst Says
DexCom Inc (NASDAQ: DXCM) raised its 2023 financial guidance following strong  
Via Benzinga
Dexcom Reports First Quarter 2023 Financial Results
From DexCom, Inc.
Via Business Wire
P/E Ratio Insights for DexCom
 
Via Benzinga
Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB
From Dexcom, Inc.
Via Business Wire
“Sell In May Effect”: Uncovering Investment Opportunities During Seasonal Weakness
Despite the seasonal weakness that is often associated with the summer months, there are still market opportunities waiting to be uncovered. 
Via Talk Markets
2 Monster Stocks to Buy Without Any Hesitation
These stocks have grown revenue, earnings and share price over the past five years. 
Via The Motley Fool
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.